Loading data
CVXNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 184.43 bn USD | 193.41 bn USD | 196.91 bn USD | 235.72 bn USD | 155.61 bn USD |
| Cost of revenue | 108.21 bn USD | 119.21 bn USD | 119.2 bn USD | 145.42 bn USD | 92.25 bn USD |
| Research and development expense | 427 m USD | 353 m USD | 320 m USD | 268 m USD | 268 m USD |
| Selling, general and administrative expense | 5.13 bn USD | 4.83 bn USD | 4.14 bn USD | 4.31 bn USD | 4.01 bn USD |
| Income tax expense | 7.26 bn USD | 9.76 bn USD | 8.17 bn USD | 14.07 bn USD | 5.95 bn USD |
| Net income (reported basis) | 12.3 bn USD | 17.7 bn USD | 21.4 bn USD | 35.5 bn USD | 15.6 bn USD |
| Basic earnings per share | 6.65 USD/share | 9.76 USD/share | 11.41 USD/share | 18.36 USD/share | 8.15 USD/share |
| Diluted earnings per share | 6.63 USD/share | 9.72 USD/share | 11.36 USD/share | 18.28 USD/share | 8.14 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.